Your browser doesn't support javascript.
Novel approach by natural language processing for COVID-19 knowledge discovery.
Wang, Li; Jiang, Lei; Pan, Dongyan; Wang, Qinghua; Yin, Zeyu; Kang, Zijian; Tian, Haoran; Geng, Xuqiang; Shao, Jinsong; Pan, Wenjie; Yin, Jian; Fang, Li; Wang, Yue; Zhang, Weide; Li, Zhixiu; Zheng, Jun; Hu, Wenxin; Pan, Yunbao; Yu, Dong; Guo, Shicheng; Lu, Wei; Li, Qiang; Zhou, Yunyun; Xu, Huji.
  • Wang L; Medical School, Nantong University, Nantong, China; Research Center for Intelligence Information Technology, Nantong University, Nantong, China.
  • Jiang L; Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • Pan D; Department of Ophthalmology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
  • Wang Q; Medical School, Nantong University, Nantong, China.
  • Yin Z; Medical School, Nantong University, Nantong, China.
  • Kang Z; Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • Tian H; Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • Geng X; Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • Shao J; Public Health School, Nantong University, Nantong, China.
  • Pan W; Medical School, Nantong University, Nantong, China.
  • Yin J; Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • Fang L; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, PA, USA.
  • Wang Y; Department of Histology & Embryology, Second Military Medical University, Shanghai, China.
  • Zhang W; Big Data and Artificial Intelligence Center, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li Z; Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.
  • Zheng J; School of Data Science & Engineering, East China Normal University, Shanghai, China.
  • Hu W; School of Data Science & Engineering, East China Normal University, Shanghai, China.
  • Pan Y; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
  • Yu D; Center for Translational Medicine, Second Military Medical University, Shanghai, China.
  • Guo S; Department of Medical Genetics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA; Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, USA.
  • Lu W; NO.905 Hospital, Shanghai, China.
  • Li Q; Department of Respiratory and Critical Care Medicine, Shanghai East Hospital, Tongji University, Shanghai, China.
  • Zhou Y; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, PA, USA.
  • Xu H; Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China; Peking-Tsinghua Center for Life Sciences, Tsinghua University, Beijing, China; School of Clinical Medicine, Tsinghua University, Beijing, China. Electronic address: xuhuji@sm
Biomed J ; 45(3): 472-481, 2022 06.
Article in English | MEDLINE | ID: covidwho-1767931
ABSTRACT

BACKGROUND:

The impact of COVID-19 on public health has mandated an 'all hands on deck' scientific response. The current clinical study and basic research on COVID-19 are mainly based on existing publications or our knowledge of coronavirus. However, efficiently retrieval of accurate, relevant knowledge on COVID-19 can pose significant challenges for researchers.

METHODS:

To improve quality in accessing important literature findings, we developed a novel natural language processing (NLP) method to automatically recognize the associations among potential targeted host organ systems, associated clinical manifestations, and pathways. We further validated these associations through clinician experts' evaluations and prioritize candidate drug targets through bioinformatics network analysis.

RESULTS:

We found that the angiotensin-converting enzyme 2 (ACE2), a receptor that SARS-CoV-2 required for cell entry, is associated with cardiovascular and endocrine organ system and diseases. Furthermore, we found SARS-CoV-2 is associated with some important pathways such as IL-6, TNF-alpha, and IL-1 beta-induced dyslipidemia, which are related to inflammation, lipogenesis, and oxidative stress mechanisms, suggesting potential drug candidates.

CONCLUSION:

We prioritized the list of therapeutic targets involved in antiviral and immune modulating drugs for experimental validation, rendering it valuable during public health crises marked by stresses on clinical and research capacity. Our automatic intelligence pipeline also contributes to other novel and emerging disease management and treatments in the future.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Biomed J Year: 2022 Document Type: Article Affiliation country: J.bj.2022.03.011

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Biomed J Year: 2022 Document Type: Article Affiliation country: J.bj.2022.03.011